On October 10, 2023, NHS England released an updated work plan for the development of specialized clinical commissioning policies, effective as of October 2, 2023. Notably, two new policies in the field of MedTech have been included in the program.
The first policy pertains to the use of Gamma Knife stereotactic radiosurgery for treating essential tremor in adults, while the second focuses on Stereotactic Ablative Radiotherapy for primary kidney cancer treatment.
These updates are part of a comprehensive collection of around 300 market access news items curated by a dedicated team. These insights are available through subscription services like “HTA Alerts” and “Reimbursement Alerts,” sourced from over 80 organizations.
Organizations seeking to stay informed about developments related to their products in Europe (reimbursement news) and worldwide (HTA news) can explore these subscription services. A complimentary, three-month trial is also available upon request.

This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.